Moon Surgical today announced it received FDA 510(k) clearance for two new features on the Maestro robotic surgical assistant ...

Moon Surgical, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for two major advancements ...

The US FDA has granted 510(k) clearance to PathAI for its digital pathology image management system, AISight Dx.

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that it has received ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

FDA approves new twice-yearly HIV prevention shot. Here's how it works By Daniel Miller Published June 19, 2025 9:56am CDT Health ...

A ginger beer drink recalled over possible salmonella contamination has been issued the highest risk classification by the U.S. Food and Drug Administration (FDA).

The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent HIV, the creator of the drug, Gilead Sciences, announced on Wednesday.

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in the U.… ...

FDA Approves Powerful Twice-Yearly Treatment to Prevent HIV Gilead’s Yeztugo will offer an alternative to treatments such as daily pills and every-other-month injections By Joseph Walker and ...

Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.